CorMedix Inc. (NASDAQ:CRMD) Receives Average Rating of “Buy” from Brokerages
CorMedix Inc. (NASDAQ:CRMD – Get Free Report) has earned a consensus rating of “Buy” from the six brokerages that are currently covering the company, MarketBeat reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12 month price target among analysts that have issued ratings on the stock in the […]
CorMedix Inc. (NASDAQ:CRMD – Get Free Report) has earned a consensus rating of “Buy” from the six brokerages that are currently covering the company, MarketBeat reports. Six equities research analysts have rated the stock with a buy recommendation. The average 12 month price target among analysts that have issued ratings on the stock in the […]
